The Availability and Portrayal of Stimulants Over the Internet

Journal of Adolescent Health

Volumn 42, Issue 5, 2008, Pages 458-465

  Schepis, Ty S ^a   Marlowe, Douglas B ^b,c   Forman, Robert F ^b,c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TREATMENT RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ALKERMES INC   (United States)

Author keywords

Adolescent; CNS stimulants; Drug source; Drugs of abuse; Internet

Indexed keywords

AMPHETAMINE; BENZPHETAMINE; METHAMPHETAMINE; METHYLPHENIDATE; PHENDIMETRAZINE; PHENDIMETRAZINE TARTRATE; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; DRUG MISUSE; DRUG USE; INTERNET; OBESITY; ONLINE SYSTEM; PRESCRIPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADOLESCENT BEHAVIOR; AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; INFORMATION SYSTEMS; INTERNET; MARKETING; PRESCRIPTIONS, DRUG; STREET DRUGS;

EID: 41749116114     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2007.11.140     Document Type: Article

References (40)

1. Medical Economics Company. Physicians' Desk Reference. 59th ed (2005), Medical Economics Company, Inc, Montvale, NJ
2. Julien R.M. A Primer of Drug Action: A Concise, Nontechnical Guide to the Actions, Uses and Side Effects of Psychoactive Drugs. 8th ed (1997), W.H. Freeman and Co, New York
3. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
4. Keating G.M., and Raffin M.J. Modafinil: A review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. CNS Drugs 19 (2005) 785-803
5. 21 USC 801. Comprehensive Drug Abuse Prevention and Control Act. 1970.
6. Compton W.M., and Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 83 Suppl 1 (2006) S4-S7
7. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: Connecting the dots. Addiction 102 (2007) 740-751
8. Johnston L.D., O'Malley P.M., Bachman J.G., et al. Monitoring the Future national survey results on drug use, 1975-2005. Volume I: Secondary school students. NIH Publication No. 06-5883 (2006), National Institute on Drug Abuse, Bethesda, MD
9. McCabe S.E., Teter C.J., and Boyd C.J. Medical use, illicit use and diversion of abusable prescription drugs. J Am Coll Health 54 (2006) 269-278
10. McCabe S.E., Teter C.J., and Boyd C.J. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs 38 (2006) 43-56
11. Poulin C. Medical and nonmedical stimulant use among adolescents: From sanctioned to unsanctioned use. Can Med Assoc J 165 (2001) 1039-1044
12. Rushton J.L., and Whitmire J.T. Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 155 (2001) 560-565
13. Thomas C.P., Conrad P., Casler R., et al. Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiat Serv 57 (2006) 63-69
14. Friedman R.A. The changing face of teenage drug abuse-the trend toward prescription drugs. N Engl J Med 354 (2006) 1448-1450
15. Partnership for a Drug-Free America. The Partnership Attitude Tracking Study (PATS): Teens in grades 7 through 12, 2005. New York: 2006.
16. McCabe S.E., and Boyd C.J. Sources of prescription drugs for illicit use. Addict Behav 30 (2005) 1342-1350
17. Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194. Rockville, MD: 2006.
18. Wilford B.B., Smith D.E., and Bucher R. Prescription stimulant sales on the Internet. Pediatr Ann 35 (2006) 575-578 581-2, 585-6
19. Food and Drug Administration. FDA alerts consumers to unsafe, misrepresented drugs purchased over the Internet. Department of Health and Human Services, Washington, DC: February 16, 2007.
20. Forman R.F., Woody G.E., McLellan T., et al. The availability of web sites offering to sell opioid medications without prescriptions. Am J Psychiatry 163 (2006) 1233-1238
21. Forman R.F., and Block L.G. The marketing of opioid medications without prescription over the Internet. J Public Policy Marketing 25 (2006) 133-146
22. Fife-Yeomans J. Stimulating debate-Ritalin prescription rates for children are raising alarm bells. Daily Telegraph, April 28, 2007.
23. Vedantam S. Millions have misused ADHD stimulant drugs, study says. Washington Post, February 25, 2006.
24. Boyer E.W., Shannon M., and Hibberd P.L. The Internet and psychoactive substance use among innovative drug users. Pediatrics 115 (2005) 302-305
25. Brewer N.T. The relation of Internet searching to club drug knowledge and attitudes. Psychol Health 18 (2003) 387-401
26. Millon P. Penthouse lab busted in methamphetamine crackdown. Associated Press Newswires, November 30, 2006.
27. Romanelli F., and Smith K.M. Clinical effects and management of methamphetamine abuse. Pharmacotherapy 26 (2006) 1148-1156
28. Google. Our search: Google technology. 2007 [Online; cited 2007 February 7]; Available at: http://www.google.com/technology/Last accessed November 6, 2007.
29. Jansen B.J., Spink A., and Pedersen J. A temporal comparison of AltaVista Web searching. J Am Soc Inform Sci Technol 56 (2005) 559-570
30. Jansen B.J., Spink A., and Saracevic T. Real life, real users, and real needs: A study and analysis of user queries on the web. Inform Process Manag 36 (2000) 207-227
31. 21 CFR § 1308. Schedules of Controlled Substances. 2001.
32. Federal Register: April 27, 2001, Volume 66, Number 82.21181-22118.
33. Erowid. Erowid Experience Vaults: Amphetamines (Adderall). 2007 [Online; cited 2007 February 12]; Available at: www.erowid.org/experiences/exp.php?ID=34319Last accessed July 25, 2007.
34. National Institute of Drug Abuse. Research Report Series-Prescription Drugs: Abuse and Addiction. NIH Publication No. 05-4881 (2005), National Institutes of Health, Rockville, MD
35. Ritter A., and Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev 25 (2006) 611-624
36. United States General Accounting Office. Internet pharmacies: Some pose safety risks for consumers. Report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, US Senate. (GAO Report No. 04-820) (2004), General Accounting Office, Washington DC
37. Hubbard W.K. March 18 (2004), U.S. House of Representatives hearing on Internet drug sales, Washington, DC
38. Rannazzisi JT. DEA congressional testimony, written statement. Washington, DC, December 13, 2005.
39. McCabe S.E., Teter C.J., and Boyd C.J. The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use Misuse 39 (2004) 1095-1116
40. McCabe S.E., Teter C.J., Boyd C.J., et al. Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health 35 (2004) 501-504